The FDA allows compounding pharmacies to produce certain medications when there are drug shortages or when a patient needs a formulation that is not commercially available
Even at lower doses, GLP-1 medications are understood to act on pathways involved in glucose regulation and appetite
While we attempt to keep our information accurate, we cannot guarantee it is an accurate representation of the latest formulation of the product
N Engl J Med 380:347357 Cannon CP, Pratley R, Dagogo-Jack S, Mancuso J, Huyck S, Masiukiewicz U, Charbonnel B, Frederich R, Gallo S, Cosentino F, Shih WJ, Gantz I, Terra SG, Cherney DZI, McGuire DK (2020) VERTIS CV Investigators
This panel specifically measures GLP-1 levels and can indicate whether exogenous GLP-1 receptor agonist activity is present